BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27196050)

  • 1. Cervical Cancer Histology, Staging and Survival before and after Implementation of Organised Cervical Screening Programme in Poland.
    Nowakowski A; Cybulski M; Buda I; Janosz I; Olszak-Wąsik K; Bodzek P; Śliwczyński A; Teter Z; Olejek A; Baranowski W
    PLoS One; 2016; 11(5):e0155849. PubMed ID: 27196050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001.
    van der Aa MA; Schutter EM; Looijen-Salamon M; Martens JE; Siesling S
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):204-9. PubMed ID: 18093720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stage IIA1 versus stage IIA2 cervical cancer: does the new staging criteria predict survival?
    Garg G; Shah JP; Toy EP; Christensen C; Deppe G; Asaad R; Morris RT
    Int J Gynecol Cancer; 2011 May; 21(4):711-6. PubMed ID: 21412165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advancing age and cervical cancer screening and prognosis.
    Sawaya GF; Sung HY; Kearney KA; Miller M; Kinney W; Hiatt RA; Mandelblatt J
    J Am Geriatr Soc; 2001 Nov; 49(11):1499-504. PubMed ID: 11890589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of the absolute number and ratio of metastatic lymph nodes in predicting postoperative survival for the International Federation of Gynecology and Obstetrics stage IA2 to IIA cervical cancer.
    Chen Y; Zhang L; Tian J; Fu X; Ren X; Hao Q
    Int J Gynecol Cancer; 2013 Jan; 23(1):157-63. PubMed ID: 23221732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. About invasive cervical cancer: a French population based study between 1998 and 2010.
    Lorin L; Bertaut A; Hudry D; Beltjens F; Roignot P; Bone-Lepinoy MC; Douvier S; Arveux P
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():1-6. PubMed ID: 26004674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan.
    Chen RJ; Lin YH; Chen CA; Huang SC; Chow SN; Hsieh CY
    Gynecol Oncol; 1999 May; 73(2):184-90. PubMed ID: 10329032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive cervical cancer and screening: what are the rates of unscreened and underscreened women in the modern era?
    Subramaniam A; Fauci JM; Schneider KE; Whitworth JM; Erickson BK; Kim K; Huh WK
    J Low Genit Tract Dis; 2011 Apr; 15(2):110-3. PubMed ID: 21263352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening histories of women with CIN 2/3 compared with women diagnosed with invasive cervical cancer: a retrospective analysis of the Norwegian Coordinated Cervical Cancer Screening Program.
    Nygård JF; Nygård M; Skare GB; Thoresen SØ
    Cancer Causes Control; 2005 May; 16(4):463-74. PubMed ID: 15953989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors of cervical cancer after a negative cytological diagnosis in Polish cervical cancer screening programme.
    Macios A; Didkowska J; Wojciechowska U; Komerska K; Glińska P; Kamiński MF; Nowakowski A
    Cancer Med; 2021 May; 10(10):3449-3460. PubMed ID: 33934537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].
    Ma R; Zhang H; Zou L; Qu Y
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):125-30. PubMed ID: 25877610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The implementation of an organised cervical screening programme in Poland: an analysis of the adherence to European guidelines.
    Nowakowski A; Cybulski M; Śliwczyński A; Chil A; Teter Z; Seroczyński P; Arbyn M; Anttila A
    BMC Cancer; 2015 Apr; 15():279. PubMed ID: 25879466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening patterns within organized programs and survival of Italian women with invasive cervical cancer.
    Zucchetto A; Ronco G; Giorgi Rossi P; Zappa M; Ferretti S; Franzo A; Falcini F; Visioli CB; Zanetti R; Biavati P; La Rosa F; Baracco S; Federico M; Campari C; De Togni A; Piffer S; Pannozzo F; Fusco M; Michiara M; Castaing M; Seghini P; Tisano F; Serraino D;
    Prev Med; 2013 Sep; 57(3):220-6. PubMed ID: 23732239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of any impact of histopathology type on prognosis in patients with early-stage adenocarcinoma and squamous cell carcinoma of the uterine cervix.
    Teke F; Yoney A; Teke M; Inal A; Urakci Z; Eren B; Zincircioglu SB; Buyukpolat MY; Ozer A; Isikdogan A; Unsal M
    Asian Pac J Cancer Prev; 2014; 15(6):2815-9. PubMed ID: 24761906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical cancer: effect of glandular cell type on prognosis, treatment, and survival.
    Davy ML; Dodd TJ; Luke CG; Roder DM
    Obstet Gynecol; 2003 Jan; 101(1):38-45. PubMed ID: 12517643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the incidence of cervical tumours by disease stage in a cytology-based screening programme.
    Bucchi L; Mancini S; Baldacchini F; Giuliani O; Ravaioli A; Vattiato R; Falcini F; Giorgi Rossi P; Campari C; Canuti D; Di Felice E; de Bianchi PS; Ferretti S;
    J Med Screen; 2020 Jun; 27(2):96-104. PubMed ID: 31690178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in definitive radiotherapy of uterine cervical cancer.
    Yalman D; Aras AB; Ozkök S; Duransoy A; Celik OK; Ozsaran Z; Haydaroğlu A
    Eur J Gynaecol Oncol; 2003; 24(3-4):309-14. PubMed ID: 12807246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nomogram prediction for overall survival of patients diagnosed with cervical cancer.
    Polterauer S; Grimm C; Hofstetter G; Concin N; Natter C; Sturdza A; Pötter R; Marth C; Reinthaller A; Heinze G
    Br J Cancer; 2012 Sep; 107(6):918-24. PubMed ID: 22871885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the New FIGO Classification for Cervical Cancer on Patient Survival: A Retrospective Analysis of 265 Histologically Confirmed Cases with FIGO Stages IA to IIB.
    de Gregorio A; Widschwendter P; Ebner F; Friedl TWP; Huober J; Janni W; de Gregorio N
    Oncology; 2020; 98(2):91-97. PubMed ID: 31593942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical Cancer in Women Aged 35 Years and Younger.
    Pelkofski E; Stine J; Wages NA; Gehrig PA; Kim KH; Cantrell LA
    Clin Ther; 2016 Mar; 38(3):459-66. PubMed ID: 26899314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.